Kezar Life Sciences, Inc.
DelistedCIK 1645666fmd_1BZVS5J6DABGPDDNZM0MQHM7DBManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2016 to Mar 31, 2026, 38 periods
Latest annual · FY2025
Millions- Total revenues
- 0
- Operating income
- (59)
- Net income
- (56)
- Free cash flow
- (52)
Latest quarter · Q1 FY2026
Millions- Operating income
- (7)
- Net income
- (6)
- Free cash flow
- (7)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2022 to FY2025
- n/m
- Revenue, 5 yearsFY2020 to FY2025
- n/m
- Net income, 5 yearsFY2020 to FY2025
- n/m
Kezar Life Sciences, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Revenue | $0 | $0 | 10-K 2026-03-27 · proof | |
| Operating income | -$59.1 million | -$90.6 million | 10-K 2026-03-27 · proof | |
| Net income | -$56 million | -$83.7 million | 10-K 2026-03-27 · proof | |
| Cash from operating activities | -$51.8 million | -$74.2 million | 10-K 2026-03-27 · proof | |
| Free cash flow | -$51.8 million | -$74.2 million | 10-K 2026-03-27 · proof | |
| Total assets | $76.6 million | $144.7 million | -47% | 10-K 2026-03-27 · proof |
| Total liabilities | $6.6 million | $27.8 million | -76.3% | 10-K 2026-03-27 · proof |
| Cash and cash equivalents | $71.9 million | $41.7 million | +72.2% | 10-K 2026-03-27 · proof |
| Total debt | $0 | $10.3 million | -100% | 10-K 2026-03-27 · proof |
- What was Kezar Life Sciences, Inc.'s revenue in fiscal 2025?
- Kezar Life Sciences, Inc. reported revenue of $0 for fiscal 2025 (the year ended Dec 31, 2025), against $0 the year before. Source: the 10-K filed with the SEC on Mar 27, 2026. SEC
- What was Kezar Life Sciences, Inc.'s operating income in fiscal 2025?
- Kezar Life Sciences, Inc. reported operating income of -$59.1 million for fiscal 2025 (the year ended Dec 31, 2025), against -$90.6 million the year before. Source: the 10-K filed with the SEC on Mar 27, 2026. SEC
- What was Kezar Life Sciences, Inc.'s net income in fiscal 2025?
- Kezar Life Sciences, Inc. reported net income of -$56 million for fiscal 2025 (the year ended Dec 31, 2025), against -$83.7 million the year before. Source: the 10-K filed with the SEC on Mar 27, 2026. SEC
- What was Kezar Life Sciences, Inc.'s cash from operating activities in fiscal 2025?
- Kezar Life Sciences, Inc. reported cash from operating activities of -$51.8 million for fiscal 2025 (the year ended Dec 31, 2025), against -$74.2 million the year before. Source: the 10-K filed with the SEC on Mar 27, 2026. SEC
- What was Kezar Life Sciences, Inc.'s free cash flow in fiscal 2025?
- Kezar Life Sciences, Inc. reported free cash flow of -$51.8 million for fiscal 2025 (the year ended Dec 31, 2025), against -$74.2 million the year before. Source: the 10-K filed with the SEC on Mar 27, 2026. SEC
- What are Kezar Life Sciences, Inc.'s total assets?
- As of Dec 31, 2025, Kezar Life Sciences, Inc. reported total assets of $76.6 million, against $144.7 million a year earlier (-47%). Source: the 10-K filed with the SEC on Mar 27, 2026. SEC
- What are Kezar Life Sciences, Inc.'s total liabilities?
- As of Dec 31, 2025, Kezar Life Sciences, Inc. reported total liabilities of $6.6 million, against $27.8 million a year earlier (-76.3%). Source: the 10-K filed with the SEC on Mar 27, 2026. SEC
- What are Kezar Life Sciences, Inc.'s cash and cash equivalents?
- As of Dec 31, 2025, Kezar Life Sciences, Inc. reported cash and cash equivalents of $71.9 million, against $41.7 million a year earlier (+72.2%). Source: the 10-K filed with the SEC on Mar 27, 2026. SEC
- What is Kezar Life Sciences, Inc.'s total debt?
- As of Dec 31, 2025, Kezar Life Sciences, Inc. reported total debt of $0, against $10.3 million a year earlier (-100%). Source: the 10-K filed with the SEC on Mar 27, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1645666&period_type=annual&limit=5"Information only, not investment advice.